Hepatic Arterial Infusion of Mitomycin C with Degradable Starch Microspheres for Unresectable Intrahepatic Cholangiocarcinoma

Clinical Oncology

Volumn 20, Issue 3, 2008, Pages 241-246

  Shitara, K ^a   Ikami, I ^b   Munakata, M ^a   Muto, O ^a   Sakata, Y ^a  

^a Misawa City Hospital   (Japan)

^b AOMORI ROSAI HOSPITAL   (Japan)

Author keywords

Degradable starch microspheres; hepatic arterial infusion chemotherapy; intrahepatic cholangiocarcinoma; mitomycin C

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; CONTRAST MEDIUM; FLUOROURACIL; GEMCITABINE; MICROSPHERE; MITOMYCIN C; PROTON PUMP INHIBITOR; STARCH;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHOLANGITIS; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG FORMULATION; DRUG INFUSION; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FATIGUE; FEASIBILITY STUDY; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER CARCINOMA; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RETREATMENT; RETROSPECTIVE STUDY; SIDE EFFECT; STOMACH ULCER; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; FEMALE; HEPATIC ARTERY; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STARCH; TREATMENT OUTCOME;

EID: 40649119627     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.12.007     Document Type: Article

References (26)

1. Ikai I., Arii S., Ichida T., et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 32 (2005) 163-172
2. West J., Wood H., Logan R.F., Quinn M., and Aithal G.P. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 94 (2006) 1751-1758
3. Khan S.A., Thomas H.C., Davidson B.R., and Taylor-Robinson S.D. Cholangiocarcinoma. Lancet 366 (2005) 1303-1314
4. Rea D.J., Munoz-Juarez M., Farnell M.B., et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139 (2004) 514-523
5. Lang H., Sotiropoulos G.C., Fruhauf N.R., et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 241 (2005) 134-143
6. Jarnagin W.R., Fong Y., DeMatteo R.P., et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234 (2001) 507-517
7. Falkson G., MacIntyre J.M., and Moertel C.G. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 54 (1984) 965-969
8. Choi C.W., Choi I.K., Seo J.H., et al. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas. Am J Clin Oncol 23 (2000) 425
9. Ducreux M., Rougier P., Fandi A., et al. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 6 (1998) 653-656
10. Gebbia V., Giuliani F., Maiello E., et al. Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. J Clin Oncol 19 (2001) 4089-4091
11. Thongprasert S., Napapan S., Charoentum C., and Moonprakan S. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol 16 (2005) 279-281
12. Arai Y., Inaba Y., and Takeuchi Y. Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga W.R. (Ed). Interventional Radiology. 3rd edn (1997), Williams & Wilkins, Baltimore 192-205
13. Arai Y., Inaba Y., Takeuchi Y., and Ariyoshi Y. Intermittent hepatic arterial infusion of high-dose 5-FU on a weekly schedule for metastases from colorectal cancer. Cancer Chemother Pharmacol 40 (1997) 526-530
14. Atiq O.T., Kemeny N., Niedzwiecki D., and Botet J. Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump. Cancer 69 (1992) 920-924
15. Cantore M., Rabbi C., Guadagni S., Zamagni D., and Aitini E. Intra-arterial hepatic chemotherapy combined with continuous infusion of 5-fluorouracil in patients with metastatic cholangiocarcinoma. Ann Oncol 13 (2002) 1687-1688
16. Tanaka N., Yamakado K., Nakatsuka A., Fujii A., Matsumura K., and Takeda K. Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma; initial experience. Eur J Radiol 41 (2002) 42-48
17. Taguchi T., Kondo M., Tanikawa K., Nakamura H., Okawa T., and Ogawa N. Comparative clinical study in metastatic liver cancer between intra-arterial infusion of mitomycin C alone and intra-arterial infusion of mitomycin C combined with PJ-203 (degradable starch microspheres). Japan J Cancer Chemother 20 (1993) 2027-2035
18. Taguchi T. Liver tumor targeting of drugs: Spherex, a vascular occlusive agent. Japan J Cancer Chemother 22 (1995) 969-976
19. Taguchi T. Chemo-occlusion for the treatment of liver cancer. A new technique using degradable starch microspheres. Clin Pharmacokinet 24 (1995) 275-291
20. Gyves J.W., Ensminger W.D., VanHarken D., Niederhuber J., Stetson P., and Walker S. Improved regional selectivity of hepatic arterial mitomycin by starch microspheres. Clin Pharmacol Ther 34 (1983) 259-265
21. Andersson M., Aronsen K.F., Balch C., et al. Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer. Acta Oncol 28 (1989) 219-222
22. Taguchi T., Tanikawa K., Sano K., et al. Multi-center cooperative phase II study of combined infusion of PJ-203 (degradable starch microspheres) into hepatic artery in metastatic liver cancer. Japan J Cancer Chemother 20 (1993) 2015-2025
23. Koike S., Fujimoto S., Guhji M., et al. Repeated intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in inoperable metastatic hepatic cancer. Japan J Cancer Chemother 15 (1998) 2601-2605
24. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
25. Furuse J., Ishii H., Satake M., et al. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. Am J Clin Oncol 26 (2003) 159-164
26. Chen J.S., Lin Y.C., Jan Y.Y., and Liau C.T. Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas. Anticancer Drugs 12 (2001) 339-343